ParkinsonCanadaV1, PascalFrancis, Curation, bibRecord, 000021

Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine

Identifieur interne : 000021 ( PascalFrancis/Curation ); précédent : 000020; suivant : 000022

Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine

Auteurs : A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Levy [Canada] ; W. Hutchison [Canada] ; J. Dostrovsky [Canada]

Source :

Annals of neurology [ 0364-5134 ] ; 2000.

RBID : Pascal:00-0262116

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Dyskinésie, Apomorphine, Agoniste, Dopamine, Electrodiagnostic, Exploration, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Agonist, Dopamine, Dyskinesia, Electrodiagnosis, Exploration, Human, Parkinson disease.

Abstract

Dopaminergic agents reverse parkinsonism but commonly induce dyskinesia in patients with Parkinson's disease (PD) on long-term levodopa therapy. The aim of this study was to determine the neurophysiologic correlates of the amelioration of parkinsonism and the involuntary movements produced by the dopamine agonist apomorphine. Seventeen PD patients were given apomorphine (2-6 mg) before surgery. Neural activity was recorded for individual neurons and for populations of neurons before and after apomorphine. Both internal (GPi) and external (GPe) segments of the globus pallidus were sampled in patients undergoing pallidal surgery. The subthalamic nucleus (STN) was sampled in STN surgery patients. Results suggest that dopaminergic agents act by decreasing GPi and STN activity, and increasing GPe activity, and that drug-induced dyskinesias results from a large reduction in GPi firing.

A01	`01`	`1`		`@0 0364-5134`
A02	`01`			`@0 ANNED3`
A03		`1`		`@0 Ann. neurol.`
A05				`@2 47`
A06				`@2 4 @3 SUP1`
A08	`01`	`1`	`ENG`	`@1 Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine`
A09	`01`	`1`	`ENG`	`@1 Levodopa-induced dyskinesias`
A11	`01`	`1`		`@1 LOZANO (A. M.)`
A11	`02`	`1`		`@1 LANG (A. E.)`
A11	`03`	`1`		`@1 LEVY (R.)`
A11	`04`	`1`		`@1 HUTCHISON (W.)`
A11	`05`	`1`		`@1 DOSTROVSKY (J.)`
A12	`01`	`1`		`@1 OLANOW (C. Warren) @9 ed.`
A14	`01`			`@1 Division of Neurosurgery, Department of Surgery, The Toronto Hospital, University of Toronto @2 Toronto @3 CAN @Z 1 aut. @Z 4 aut.`
A14	`02`			`@1 Division of Neurology, Department of Medicine, University of Toronto @2 Toronto @3 CAN @Z 2 aut.`
A14	`03`			`@1 Department of Physiology, University of Toronto @2 Toronto @3 CAN @Z 3 aut. @Z 4 aut. @Z 5 aut.`
A15	`01`			`@1 Department of Neurology, Mount Sinai School of Medicine, 1 Gustave Levy Place, Annenburg 14-94 @2 New York, NY 10029 @3 USA @Z 1 aut.`
A20				`@2 S141-S146`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 16555 @5 354000082146950150`
A44				`@0 0000 @1 © 2000 INIST-CNRS. All rights reserved.`
A45				`@0 37 ref.`
A47	`01`	`1`		`@0 00-0262116`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Annals of neurology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Dopaminergic agents reverse parkinsonism but commonly induce dyskinesia in patients with Parkinson's disease (PD) on long-term levodopa therapy. The aim of this study was to determine the neurophysiologic correlates of the amelioration of parkinsonism and the involuntary movements produced by the dopamine agonist apomorphine. Seventeen PD patients were given apomorphine (2-6 mg) before surgery. Neural activity was recorded for individual neurons and for populations of neurons before and after apomorphine. Both internal (GPi) and external (GPe) segments of the globus pallidus were sampled in patients undergoing pallidal surgery. The subthalamic nucleus (STN) was sampled in STN surgery patients. Results suggest that dopaminergic agents act by decreasing GPi and STN activity, and increasing GPe activity, and that drug-induced dyskinesias results from a large reduction in GPi firing.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Dyskinésie @5 04`
C03	`02`	`X`	`ENG`	`@0 Dyskinesia @5 04`
C03	`02`	`X`	`SPA`	`@0 Disquinesia @5 04`
C03	`03`	`X`	`FRE`	`@0 Apomorphine @2 NK @2 FR @5 07`
C03	`04`	`X`	`FRE`	`@0 Agoniste @5 08`
C03	`04`	`X`	`ENG`	`@0 Agonist @5 08`
C03	`04`	`X`	`SPA`	`@0 Agonista @5 08`
C03	`05`	`X`	`FRE`	`@0 Dopamine @2 NK @2 FR @5 09`
C03	`05`	`X`	`ENG`	`@0 Dopamine @2 NK @2 FR @5 09`
C03	`05`	`X`	`SPA`	`@0 Dopamina @2 NK @2 FR @5 09`
C03	`06`	`X`	`FRE`	`@0 Electrodiagnostic @5 10`
C03	`06`	`X`	`ENG`	`@0 Electrodiagnosis @5 10`
C03	`06`	`X`	`SPA`	`@0 Electrodiagnóstico @5 10`
C03	`07`	`X`	`FRE`	`@0 Exploration @5 17`
C03	`07`	`X`	`ENG`	`@0 Exploration @5 17`
C03	`07`	`X`	`SPA`	`@0 Exploración @5 17`
C03	`08`	`X`	`FRE`	`@0 Homme @5 20`
C03	`08`	`X`	`ENG`	`@0 Human @5 20`
C03	`08`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`06`	`X`	`FRE`	`@0 Trouble neurologique @5 46`
C07	`06`	`X`	`ENG`	`@0 Neurological disorder @5 46`
C07	`06`	`X`	`SPA`	`@0 Trastorno neurológico @5 46`
C07	`07`	`X`	`FRE`	`@0 Mouvement involontaire @5 47`
C07	`07`	`X`	`ENG`	`@0 Involuntary movement @5 47`
C07	`07`	`X`	`SPA`	`@0 Movimiento involuntario @5 47`
N21				`@1 178`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D03

Links to Exploration step

Pascal:00-0262116

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine</title>
<author><name sortKey="Lozano, A M" sort="Lozano, A M" uniqKey="Lozano A" first="A. M." last="Lozano">A. M. Lozano</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurosurgery, Department of Surgery, The Toronto Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Levy, R" sort="Levy, R" uniqKey="Levy R" first="R." last="Levy">R. Levy</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physiology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Hutchison, W" sort="Hutchison, W" uniqKey="Hutchison W" first="W." last="Hutchison">W. Hutchison</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurosurgery, Department of Surgery, The Toronto Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physiology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dostrovsky, J" sort="Dostrovsky, J" uniqKey="Dostrovsky J" first="J." last="Dostrovsky">J. Dostrovsky</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physiology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0262116</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0262116 INIST</idno>
<idno type="RBID">Pascal:00-0262116</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D03</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000021</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine</title>
<author><name sortKey="Lozano, A M" sort="Lozano, A M" uniqKey="Lozano A" first="A. M." last="Lozano">A. M. Lozano</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurosurgery, Department of Surgery, The Toronto Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Levy, R" sort="Levy, R" uniqKey="Levy R" first="R." last="Levy">R. Levy</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physiology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Hutchison, W" sort="Hutchison, W" uniqKey="Hutchison W" first="W." last="Hutchison">W. Hutchison</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurosurgery, Department of Surgery, The Toronto Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physiology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dostrovsky, J" sort="Dostrovsky, J" uniqKey="Dostrovsky J" first="J." last="Dostrovsky">J. Dostrovsky</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Physiology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Annals of neurology</title>
<title level="j" type="abbreviated">Ann. neurol.</title>
<idno type="ISSN">0364-5134</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Annals of neurology</title>
<title level="j" type="abbreviated">Ann. neurol.</title>
<idno type="ISSN">0364-5134</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Dopamine</term>
<term>Dyskinesia</term>
<term>Electrodiagnosis</term>
<term>Exploration</term>
<term>Human</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Dyskinésie</term>
<term>Apomorphine</term>
<term>Agoniste</term>
<term>Dopamine</term>
<term>Electrodiagnostic</term>
<term>Exploration</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Dopaminergic agents reverse parkinsonism but commonly induce dyskinesia in patients with Parkinson's disease (PD) on long-term levodopa therapy. The aim of this study was to determine the neurophysiologic correlates of the amelioration of parkinsonism and the involuntary movements produced by the dopamine agonist apomorphine. Seventeen PD patients were given apomorphine (2-6 mg) before surgery. Neural activity was recorded for individual neurons and for populations of neurons before and after apomorphine. Both internal (GPi) and external (GPe) segments of the globus pallidus were sampled in patients undergoing pallidal surgery. The subthalamic nucleus (STN) was sampled in STN surgery patients. Results suggest that dopaminergic agents act by decreasing GPi and STN activity, and increasing GPe activity, and that drug-induced dyskinesias results from a large reduction in GPi firing.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0364-5134</s0>
</fA01>
<fA02 i1="01"><s0>ANNED3</s0>
</fA02>
<fA03 i2="1"><s0>Ann. neurol.</s0>
</fA03>
<fA05><s2>47</s2>
</fA05>
<fA06><s2>4</s2>
<s3>SUP1</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Levodopa-induced dyskinesias</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>LOZANO (A. M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LANG (A. E.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>LEVY (R.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HUTCHISON (W.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DOSTROVSKY (J.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>OLANOW (C. Warren)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Division of Neurosurgery, Department of Surgery, The Toronto Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Physiology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Neurology, Mount Sinai School of Medicine, 1 Gustave Levy Place, Annenburg 14-94</s1>
<s2>New York, NY 10029</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA20><s2>S141-S146</s2>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>16555</s2>
<s5>354000082146950150</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>37 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0262116</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Annals of neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Dopaminergic agents reverse parkinsonism but commonly induce dyskinesia in patients with Parkinson's disease (PD) on long-term levodopa therapy. The aim of this study was to determine the neurophysiologic correlates of the amelioration of parkinsonism and the involuntary movements produced by the dopamine agonist apomorphine. Seventeen PD patients were given apomorphine (2-6 mg) before surgery. Neural activity was recorded for individual neurons and for populations of neurons before and after apomorphine. Both internal (GPi) and external (GPe) segments of the globus pallidus were sampled in patients undergoing pallidal surgery. The subthalamic nucleus (STN) was sampled in STN surgery patients. Results suggest that dopaminergic agents act by decreasing GPi and STN activity, and increasing GPe activity, and that drug-induced dyskinesias results from a large reduction in GPi firing.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dyskinésie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dyskinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Disquinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Agoniste</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Agonist</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Agonista</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Electrodiagnostic</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Electrodiagnosis</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Electrodiagnóstico</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Exploration</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Exploración</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>46</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>47</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>47</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>47</s5>
</fC07>
<fN21><s1>178</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000021 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000021 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:00-0262116
   |texte=   Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine

Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri